Faculty Collaboration Database

Ocular dysmotility after intra-arterial chemotherapy for retinoblastoma. J AAPOS 2015 Dec;19(6):574-7

Date

12/23/2015

Pubmed ID

26691048

DOI

10.1016/j.jaapos.2015.08.007

Scopus ID

2-s2.0-84962208482 (requires institutional sign-in at Scopus site)   4 Citations

Abstract

We report the case of a 15-month-old boy with retinoblastoma who developed exotropia secondary to a right medial rectus infarct after intra-arterial chemotherapy. He had unilateral sporadic group C tumor (International Classification of Retinoblastoma) and was treated with intra-arterial melphalan. One week after the first session of intra-ophthalmic arterial melphalan chemotherapy, he was noted to have orbital congestion, exotropia, and right adduction limitation. Magnetic resonance imaging was suggestive of a right medial rectus infarct. The tumor showed a good response to intra-arterial chemotherapy but the exotropia persisted.

Author List

Lambert NG, Winegar BA, Feola GP, Ramasubramanian A

Author

Aparna Ramasubramanian MD Associate Professor in the Ophthalmology and Visual Sciences department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Antineoplastic Agents, Alkylating
Edema
Exotropia
Fluorescein Angiography
Humans
Infant
Infarction
Infusions, Intra-Arterial
Ischemia
Magnetic Resonance Imaging
Male
Melphalan
Muscular Diseases
Oculomotor Muscles
Ophthalmic Artery
Papilledema
Radiography
Retinal Neoplasms
Retinoblastoma